Diabetic nephropathy poses a major life-threatening consequence for the patient with either type I or type II diabetes mellitus. Although glycemic control has been implicated in preventing or reversing the functional and structural manifestations of diabetic nephropathy (especially in experimental animals), the long-term effects of near-normal glycemic control on preventing or reversing the progression of diabetic renal lesions in man have not been rigorously examined. Pancreas transplantation to patients with type I diabetes mellitus provides the opportunity to effect long-term euglycemia under several venues: simultaneous pancreas and kidney transplantation alone. Studies of renal biopsies and renal function occurring at the time of pancreas transplantation and at 2 and 5 years (and in some cases 10 years) later yield quantitative morphometric analyses of glomerular structure and measures of glomerular filtration rate and renal blood flow. The primary endpoint in all cases will be the expansion of the glomerular mesangium by measuring its volume fraction and total volume in the glomerulus. Secondary endpoints include glomerular basement membrane width, mesangial matrix volume and measures of renal function. Three different specific aims can be addressed: the prevention of renal lesions of diabetic nephropathy with euglycemia established by concurrent pancreas/kidney transplantation; the halting or reversal of the progression of early renal lesions present in the previously transplanted kidney with subsequent pancreas transplantation; and the amelioration of established renal lesions in patients with their own kidneys who received pancreas transplantation alone. Diabetic and non-diabetic recipients of renal transplants alone constitute control groups with which to compare the results from the renal transplant recipients who also received pancreatic transplants, as do untreated diabetic patients when compared to recipients of pancreas transplants alone. Since pancreas transplantation has become a more frequently applied procedure to manage the patient with type I diabetes mellitus, the studies proposed will address the potential efficacy of the procedure in altering the course of diabetic nephropathy. With the extended period of time necessary to follow the course of diabetic renal disease, an immediate application of techniques to study diabetic renal disease and pancreas transplantation has the potential to address its efficacy in the shortest period of time and to contribute broadly to understanding the stage(s) of diabetic nephropathy ultimately benefiting from the establishment of a continuous euglycemic state.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK043605-03
Application #
3244980
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Project Start
1991-05-01
Project End
1995-04-30
Budget Start
1993-05-01
Budget End
1994-04-30
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Degenhardt, Thorsten P; Alderson, Nathan L; Arrington, David D et al. (2002) Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Kidney Int 61:939-50
Moriya, T; Groppoli, T J; Kim, Y et al. (2001) Quantitative immunoelectron microscopy of type VI collagen in glomeruli in type I diabetic patients. Kidney Int 59:317-23
Trevisan, R; Fioretto, P; Barbosa, J et al. (1999) Insulin-dependent diabetic sibling pairs are concordant for sodium-hydrogen antiport activity. Kidney Int 55:2383-9
Fioretto, P; Kim, Y; Mauer, M (1998) Diabetic nephropathy as a model of reversibility of established renal lesions. Curr Opin Nephrol Hypertens 7:489-94
Fioretto, P; Steffes, M W; Sutherland, D E et al. (1998) Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339:69-75
Li, Y M; Steffes, M; Donnelly, T et al. (1996) Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine. Proc Natl Acad Sci U S A 93:3902-7
Yagame, M; Kim, Y; Zhu, D et al. (1995) Differential distribution of type IV collagen chains in patients with diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 70:42-8
Zhu, D; Kim, Y; Steffes, M W et al. (1994) Glomerular distribution of type IV collagen in diabetes by high resolution quantitative immunochemistry. Kidney Int 45:425-33
Zhu, D; Kim, Y; Steffes, M W et al. (1994) Application of electron microscopic immunocytochemistry to the human kidney: distribution of type IV and type VI collagen in normal human kidney. J Histochem Cytochem 42:577-84
Basgen, J M; Steffes, M W; Stillman, A E et al. (1994) Estimating glomerular number in situ using magnetic resonance imaging and biopsy. Kidney Int 45:1668-72

Showing the most recent 10 out of 15 publications